Market Tracker

10/23 4:21am ET

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

2.30
Data as of Oct 22
 -0.06 / -2.54%
Today’s Change
2.05
Today|||52-Week Range
5.30
-40.87%
Year-to-Date

Today’s Trading

Previous close2.36
Today’s open2.36
Day’s range-- - --
Volume244,537
Average volume (3 months)459,316
Market cap$221.0M
Dividend yield--
Data as of 10/22/2014

Growth & Valuation

Earnings growth (last year)-130.77%
Earnings growth (this year)--
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-66.56%
P/E ratioNM
Price/Sales31.21
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BPTHBio-Path Holdings In...-0.03-1.24%
VSTMVerastem Inc+0.01+0.11%
CURNeuralstem Inc-0.04-1.49%
PSTIPluristem Therapeuti...-0.04-1.35%
Data as of 10/22/2014

Financials

Next reporting dateDecember 3, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$11.5M
Annual profit (last year)-$27.8M
Net profit margin-241.38%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
David Aviezer
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, --

Forecasts